NEWS

Updates on OXGENE's Discovery and Biomanufacturing technologies

14 April 2022

Chimeric enters partnership with WuXi Advanced Therapies

Chimeric Therapeutics will leverage WuXi Advanced Therapies’ (“WuXi ATU”) closed loop CAR T platform and other capabilities to accelerate the clinical development of their CHM 1101 (CLTX CAR T) and...

View Details

Launch of TESSA™ Technology

07 Mar 2022

EMA GMP Certification for new testing facility

06 Jan 2022

Hemogenyx Pharmaceuticals partnership with WuXi ATU

20 Dec 2021

WuXi AppTec acquire OXGENE

02 Mar 2021

Introducing SLIM display

12 Jan 2021

TESSA Technology Launch

22 Sep 2020

OXGENE reports 100% revenue growth

06 May 2020

Fujifilm Partnership

23 Apr 2020

The Native Antigen Company Collaboration

02 Apr 2020

Vaccitech License

08 Jan 2020

First license in Asia

11 Dec 2019

Abcam agreement

25 Sep 2019